ArticlePloS one2025
Association between albumin infusion and sepsis risk of patients with acute pancreatitis.
Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveTo investigate whether early administration of serum albumin infusion in the acute pancreatitis (AP) patients admitted to the intensive care unit (ICU) reduces the risk of sepsis.
methodsData were collected from the Medical Information Mart for Intensive Care III and IV databases for this retrospective cohort study. The primary outcome was the occurrence of sepsis in AP patients. We used univariate and multivariate logistic regression models to evaluate the association between albumin infusion and sepsis risk of AP patients. Additional subgroup analysis by stratification to serum albumin were also performed.
resultsThe study included 779 patients with AP. They were divided into a sepsis group (83 patients) and a non-sepsis group (696 patients) according to whether they developed sepsis, and the prevalence of sepsis was approximately 10.65%. Multivariate logistic regression model indicated that albumin infusion was associated with decreased risk of sepsis in the AP patients [adjusted odds ratio (OR)=0.37, 95% confidence interval (CI)=0.13-0.88]. Subgroup analysis showed a negative association between the albumin infusion and sepsis risk in the AP patients with serum albumin ≤ 3.5g/L (adjusted OR=0.29, 95%CI = 0.08-0.77).
conclusionIn this study, we found an association between albumin administration and a lower risk of sepsis in AP patients, which persisted after multivariate adjustment. This suggests that albumin infusion may have unique potential benefits for this population.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.